Agios Pharmaceuticals Inc (AGIO)
EBITDA Growth
1.41%
Quarterly · Period ending:
AGIO EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported1.41%period ending
Latest reported1.41%period ending
AGIO Quarterly EBITDA YoY % (-33.94% → 1.41%)
Year-over-year change
High-resolution chart · PNG
AGIO ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| 1.4075% | |
| -11.0634% | |
| -3.6114% | |
| -110.1817% | |
| -17.1764% | |
| -9.738% | |
| -10.0437% | |
| 1,217.468% | |
| -15.2758% | |
| -1.2281% | |
| -346.5754% | |
| -12.4552% | |
| 8.3964% | |
| 14.1588% | |
| 139.7792% | |
| 2.7837% | |
| -11.4091% | |
| -4.4096% | |
| -8.3358% | |
| 5.5779% | |
| 6.5873% | |
| -133.9686% | |
| 14.4278% | |
| 16.5182% | |
| 20.2348% | |
| 60.4286% | |
| -10.081% | |
| -6.908% | |
| -51.431% | |
| -3.4577% | |
| -6.7465% | |
| -25.7897% | |
| 14.2327% | |
| -40.9909% | |
| -58.8809% | |
| -24.6907% | |
| -50.5039% | |
| -192.8942% | |
| -40.0825% | |
| -57.4414% | |
| -75.9513% | |
| -363.171% | |
| -50.7794% | |
| -1,209.3979% | |
| -74.1543% | |
| 59.6302% | |
| -121.5174% | |
| 133.2398% | |
| -120.8415% | |
| -78.468% | |
| -92.7762% | |
| -123.1684% | |
| -39.3504% | |
| -33.94% |